ArticleClinics (Sao Paulo, Brazil)2026

Combination of serum TBL1XR1, MFAP5, and PSA as diagnostic biomarkers for prostate cancer.

Xianxian Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.